Jim Simons Renaissance Technologies
Jim Simons is the founder of Renaissance Technologies, one of the most successful quantitative hedge funds in the world. Before his career in finance, he served as a mathematics professor and made significant contributions to differential geometry. Simons applied his analytical expertise to develop sophisticated, algorithm-driven trading strategies, earning consistently high returns for investors.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
IBM
IBM
|
+$328M |
| 2 |
Johnson & Johnson
JNJ
|
+$229M |
| 3 |
GE Aerospace
GE
|
+$156M |
| 4 |
Target
TGT
|
+$155M |
| 5 |
Walt Disney
DIS
|
+$153M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$283M |
| 2 |
Eli Lilly
LLY
|
+$211M |
| 3 |
Microsoft
MSFT
|
+$199M |
| 4 |
Bristol-Myers Squibb
BMY
|
+$184M |
| 5 |
Citigroup
C
|
+$177M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 14.03% |
| 2 | Healthcare | 12.1% |
| 3 | Consumer Discretionary | 11.99% |
| 4 | Consumer Staples | 11.92% |
| 5 | Industrials | 10.22% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
WP
726
DELISTED
Worldpay, Inc.
WP
| $11.8M | 0.03% |
421,900
-231,100
| -35% | -$6.3M |
|
727
IAMGOLD
IAG
$10.3B
| $11.8M | 0.03% |
2,475,596
-971,400
| -28% | -$5.09M |
|
|
PRMW
728
DELISTED
Primo Water Corporation
PRMW
| $11.8M | 0.03% |
1,528,400
-385,300
| -20% | -$3.14M |
|
729
CVR Energy
CVI
$3.52B
| $11.7M | 0.03% |
304,600
-358,200
| -54% | -$15.7M |
|
|
QEP
730
DELISTED
QEP RESOURCES, INC.
QEP
| $11.7M | 0.03% |
423,300
+351,500
| +490% | +$10.2M |
|
731
New Oriental
EDU
$8.49B
| $11.6M | 0.03% |
466,300
+280,300
| +151% | +$6.4M |
|
|
ENDP
732
DELISTED
Endo International plc
ENDP
| $11.6M | 0.03% |
254,940
-7,353
| -3% | -$296K |
|
|
AJRD
733
DELISTED
Aerojet Rocketdyne Holdings
AJRD
| $11.5M | 0.03% |
719,495
-164,000
| -19% | -$2.69M |
|
|
BMR
734
DELISTED
BIOMED REALTY TRUST INC
BMR
| $11.5M | 0.03% |
618,800
+47,700
| +8% | +$936K |
|
735
Associated Banc-Corp
ASB
$6.07B
| $11.5M | 0.03% |
741,679
+397,335
| +115% | +$6.54M |
|
|
TXNM
736
TXNM Energy Inc
TXNM
$5.91B
| $11.4M | 0.03% |
505,300
+125,400
| +33% | +$2.85M |
|
|
NVMI
737
Nova
NVMI
$12.9B
| $11.4M | 0.03% |
1,284,000
+56,400
| +5% | +$503K |
|
738
Emergent Biosolutions
EBS
$233M
| $11.4M | 0.03% |
597,511
-126,300
| -17% | -$2.25M |
|
|
UMPQ
739
DELISTED
Umpqua Holdings Corp
UMPQ
| $11.3M | 0.03% |
698,919
+557,100
| +393% | +$9.19M |
|
|
ARRS
740
DELISTED
ARRIS International plc Ordinary Shares
ARRS
| $11.2M | 0.03% |
657,620
-759,600
| -54% | -$12.1M |
|
741
VEON
VEON
$3.92B
| $11.2M | 0.03% |
38,132
+13,672
| +56% | +$3.64M |
|
|
CS
742
DELISTED
Credit Suisse Group
CS
| $11.2M | 0.03% |
+366,600
| New | +$10.9M |
|
|
EXK
743
Endeavour Silver
EXK
$3.14B
| $11.2M | 0.03% |
2,594,000
-1,213,399
| -32% | -$5.16M |
|
744
Copa Holdings
CPA
$5.54B
| $11.1M | 0.03% |
80,100
+14,800
| +23% | +$2.03M |
|
745
CGI
GIB
$15.3B
| $11.1M | 0.03% |
316,200
-8,300
| -3% | -$270K |
|
|
TRIB
746
Trinity Biotech
TRIB
$7.86M
| $11.1M | 0.03% |
3,388
+688
| +25% | +$2.01M |
|
|
SBNY
747
DELISTED
Signature Bank
SBNY
| $11M | 0.03% |
120,574
-47,000
| -28% | -$4.23M |
|
|
BBL
748
DELISTED
BHP Group Plc American Depositary Shares (Each representing two Ordinary Shares)
BBL
| $11M | 0.03% |
+187,300
| New | +$10.9M |
|
749
Forward Air
FWRD
$658M
| $11M | 0.03% |
273,239
-14,032
| -5% | -$535K |
|
750
National Healthcare
NHC
$3.47B
| $11M | 0.03% |
232,800
+4,300
| +2% | +$206K |
|
Similar funds
Jim Simons's Q3 2013 Portfolio in Review
As of Q3 2013, Jim Simons held 3,196 positions worth $41.2B, up 8.1% from $38.1B the previous quarter. Its ten largest holdings account for 11% of the portfolio.
Jim Simons's Q3 2013 filing shows 439 new, 1,284 increased, 1,031 reduced and 412 closed positions. Its largest new stake was GE Aerospace: 1,361,721 shares worth $156M. The largest sale was Apple, an estimated $283M.
By sector, the portfolio is most concentrated in Technology at 14% of assets, down from 14% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- Jim Simons's largest Q3 2013 buy was GE Aerospace: 1,361,721 shares worth $156M.
- Jim Simons added most to IBM in Q3 2013, an estimated $328M increase.
- Jim Simons's biggest Q3 2013 reduction was Eli Lilly, cutting an estimated $211M.
- Jim Simons fully exited Apple in Q3 2013, selling an estimated $283M.
- Jim Simons's ten largest holdings make up 11% of its $41.2B portfolio in Q3 2013.
- Jim Simons opened 439 new positions and closed 412 in Q3 2013.
- Jim Simons's portfolio value rose 8.1% quarter-over-quarter to $41.2B.
Based on Renaissance Technologies's 13F filing for Q3 2013, filed 13 Nov 2013.